Skip links
Skip to content
Contact Us
Search
Search
Who We Serve
Patients
Providers
Biopharma
Payors
Therapeutic Areas
Allergy & Immunology
Cardiology
Cell & Gene Therapy
Genetics
Neurology
Pulmonology
View All
Therapies
Solutions
Specialty Pharmacy
Patient Services Hub
Third-Party Logistics
Home Infusion & Nursing
About
Our Story
Leadership
Patient Stories
Resources
Accreditations
Careers
Send a Prescription
Contact Us
Prescribe a Therapy
Orsini is the exclusive specialty pharmacy provider for MIPLYFFA™ (arimoclomol), the first FDA-approved treatment for Niemann-Pick disease type C.
Learn more →
Toggle navigation
Who We Serve
Patients
Providers
Biopharma
Payors
Therapeutic Areas
Allergy & Immunology
Cardiology
Cell & Gene Therapy
Genetics
Neurology
Pulmonology
View All
Therapies
Solutions
Specialty Pharmacy
Patient Services Hub
Third-Party Logistics
Home Infusion & Nursing
About
Our Story
Leadership
Patient Stories
Resources
Accreditations
Careers
Send a Prescription
Contact Us
Resources
Orsini Resources
All
Blog Posts
In the News
Videos
White Papers
All
Blog Posts
In the News
Videos
White Papers
Orsini Launches ORBIT™ (Orsini Rare Business Intelligence Technology) to Enhance Rare Disease Patient Care
Orsini Chosen as the Exclusive Specialty Pharmacy Provider for MIPLYFFA™ (arimoclomol), the First FDA-Approved Treatment for Niemann-Pick Disease Type C
[Video] Rare Disease Patient Management
Specialty Pharmacy Continuum: Specialty Pharmacies’ Role in Gene Therapy
Orsini Now Dispensing Livdelzi (seladelpar), for Treatment of Rare Liver Disease
Zevra Therapeutics Transitions to Orsini as the Specialty Pharmacy Provider for OLPRUVA® (sodium phenylbutyrate), a Treatment for Certain Urea Cycle Disorders
[Video] Gene Therapy Patient Case Management
Specialty Pharmacy Continuum: Gene Therapy a Hot Trend in Cold Chain
Orsini Announcement: Orsini Specialty Pharmacy Chosen to Dispense YARGESA (miglustat)
White Paper: Optimizing Patient Care in Rare Hematologic Conditions: Novel Therapies in Classical Hematology and the Role of Specialty Pharmacy in Driving Enhanced Outcomes
Orsini Announcement: Orsini Specialty Pharmacy Welcomes Two Executive Leadership Hires
Orsini selected as the exclusive specialty pharmacy for WAINUA (eplontersen) for adults with hereditary transthyretin-mediated amyloid polyneuropathy
Orsini Specialty Pharmacy Selected as Distribution Partner for Adzynma (ADAMTS13, recombinant-krhn), a Newly Approved Treatment for an Ultra-Rare Blood Clotting Disorder
Orsini Specialty Pharmacy Partners with Amicus Therapeutics to Dispense New Therapy for the Treatment of Late-Onset Pompe Disease
Orsini Specialty Pharmacy Names Darin DeCarlo Chief Growth Officer
Orsini Specialty Pharmacy Selected to be the Exclusive Specialty Pharmacy Partner for VEOPOZ™ (pozelimab-bbfg), the First and Only Treatment for CHAPLE Disease
Orsini Selected by BioMarin to Dispense ROCTAVIAN™, the First Gene Therapy for the Treatment of Severe Hemophilia A
Orsini selected as the exclusive specialty pharmacy for WAINUA (eplontersen) for adults with hereditary transthyretin-mediated amyloid polyneuropathy
Optimizing Patient Care Services with Rare Disease Limited Distribution Drugs
Now In Stock: ADZYNMA (ADAMTS13, recombinant-krhn), for patients with cTTP
Orsini Specialty Pharmacy Selected as Distribution Partner for Adzynma (ADAMTS13, recombinant-krhn), a Newly Approved Treatment for an Ultra-Rare Blood Clotting Disorder
Orsini Specialty Pharmacy Partners with Amicus Therapeutics to Dispense New Therapy for the Treatment of Late-Onset Pompe Disease
The Burden of Prior Authorizations: How Specialty Pharmacies Can Help
Importance of Hand Hygiene in Healthcare: Handwashing Awareness Week
Choosing a Specialty Pharmacy to Support ERT Therapies
Demystifying Four Common Pain Points for Patients Living with Rare Diseases
5 Ways COVID-19 Impacts Immunocompromised & Rare Disease Patients
3 Opportunities for Patients with Rare & Complex Diseases in the Time of COVID-19
Choosing a Specialty Pharmacy to Support Hereditary ATTR Amyloidosis Patients
7 Facts About Rare Diseases to Raise Awareness on Rare Disease Day
Six Reasons the Specialty Pharmacist Role is Increasingly Important
What Makes Orsini Special? Meet Our Specialty Pharmacists
Choosing a Specialty Pharmacy to Support Idiopathic Pulmonary Fibrosis Patients
Six Ways to Help Patients Manage Rare Diseases
Six Ways the Right Specialty Pharmacy Partner Helps Improve Medication Adherence
Five Ways to Define and Redefine Rare Diseases
What is a Specialty Pharmacy?
Medical Benefits Billing for Specialty Therapies
Orsini Specialty Pharmacy Selected as a Limited Distribution Partner for AMVUTTRA™ (vutrisiran)
Orsini Specialty Pharmacy Selected by Marinus Pharmaceuticals as the Exclusive Specialty Pharmacy Partner for ZTALMY®
Choosing a Specialty Pharmacy to Support Pompe Disease Patients
7 Helpful Facts to Raise Awareness for Duchenne Muscular Dystrophy (DMD)
Choosing a Specialty Pharmacy to Support Patients with X-linked hypophosphatemia
Six Ways Orsini Ensures No Patient is Left Behind
Orsini Salutes Healthcare Quality Week
Choosing a Specialty Pharmacy to Support Mucopolysaccharidosis (MPS) Patients
Orsini Specialty Pharmacy Selected by Provention Bio as a Limited Distribution Partner for TZIELD
Choosing a Specialty Pharmacy to Support Tardive Dyskinesia Patients
Payor Considerations When Evaluating a Specialty Pharmacy Partner
From Diagnosis to Treatment: The Difficulties Rare Disease Patients Encounter
Orsini Specialty Pharmacy Earns Rare Disease Pharmacy Center of Excellence Designation from URAC
Rare Disease Day: A Reminder of Our Immense Responsibility to Serve Patients and Families
Rare Disease Day: In Loving Memory of Tommy
The 3 Distribution Models to Choose for a Specialty Drug Launch
Why You Need a Limited Distribution Network for Rare Disease Drugs
The Importance of Payor Credentialing When Selecting a Specialty Pharmacy Partner
Orsini Specialty Pharmacy Selected as part of the Limited Specialty Pharmacy Network For VYJUVEK™
Operational Challenges Payors Face with Rare Disease Limited Distribution Drugs
Choosing a Specialty Pharmacy to Support Patients with Recurrent Pericarditis
Orsini Specialty Pharmacy Now Dispensing VOWST™ (fecal microbiota spores, live – brpk)
Orsini Selected by Sarepta Therapeutics to Dispense ELEVIDYS (delandistrogene moxeparvovec-rokl), the First Gene Therapy to Treat Duchenne Muscular Dystrophy
7 Factors Payors Should Consider When Choosing a Specialty Pharmacy Partner
Orsini Specialty Pharmacy Selected by Glaukos® Corporation as a Specialty Distribution Partner for Photrexa® and Photrexa® Viscous
[eBook] Living with Duchenne Muscular Dystrophy (DMD): Tommy’s Story
Choosing a Specialty Pharmacy to Support Spinal Muscular Atrophy
Orsini Specialty Pharmacy Selected to be the Exclusive Specialty Pharmacy Partner for Evkeeza™
Rare Disease Day: Raising Awareness for Patients Living with Rare Diseases
[Video] The Value of a Specialty Pharmacy Partner for Manufacturers
Orsini Specialty Pharmacy Selected by Sarepta Therapeutics as a Limited Distribution Partner for AMONDYS 45 (casimersen)
How to Manage the Administrative Burden of Prior Authorization
[eBook] Living with Spinal Muscular Atrophy: Sienna & Wesley’s Stories
Orsini Specialty Pharmacy Selected by PTC Therapeutics as a Limited Distribution Partner for EMFLAZA® (deflazacort)
5 Services Providers Should Expect from a Specialty Pharmacy
Choosing a Specialty Pharmacy to Support Duchenne Muscular Dystrophy
Importance of the ACHC Distinction in Rare Diseases and Orphan Drugs for a Specialty Pharmacy Partner
Orsini Specialty Pharmacy Selected by Alnylam® Pharmaceuticals as Limited Distribution Partner for OXLUMO™
Choosing a Specialty Pharmacy to Support Hereditary Angioedema
Orsini Specialty Pharmacy Selected by Glaukos® Corporation as a Specialty Distribution Partner for Photrexa® and Photrexa® Viscous
[eBook] Living with Duchenne Muscular Dystrophy (DMD): Tommy’s Story
Choosing a Specialty Pharmacy to Support Spinal Muscular Atrophy
Orsini Specialty Pharmacy Selected to be the Exclusive Specialty Pharmacy Partner for Evkeeza™
Rare Disease Day: Raising Awareness for Patients Living with Rare Diseases
[Video] The Value of a Specialty Pharmacy Partner for Manufacturers
How to Manage the Administrative Burden of Prior Authorization
[Video] How a Specialty Pharmacy Can Make All the Difference for Patients
3 Proven Ways to Help Patients Manage the Costs of Specialty Medications for Rare Conditions
[Patient Story] Living with Hereditary ATTR amyloidosis: Dennis’ Story
Gene Therapy Guides Future Treatment for Rare Diseases
COVID-19 Lengthens the Journey to Health Equity for Rare Disease Patients
8 Facts to Know About Mucopolysaccharidosis on MPS Awareness Day
6 Important Facts to Know About Hereditary Angioedema
Patients Share Their Journeys Living with Rare & Complex Diseases
Clinical & Operational Services to Consider When Selecting a Specialty Pharmacy Partner
Pharmaceutical Manufacturer & Payor Expectations When Partnering with a Specialty Pharmacy
6 Facts About Alzheimer’s Disease
Communication & Collaboration Between a Pharmaceutical Manufacturer and Specialty Pharmacy
Orsini Specialty Pharmacy Selected to Dispense Aduhelm™ for the Treatment of Alzheimer’s Disease
Orsini Specialty Pharmacy Offers Patients Access to Generic Treatment for Severe Homozygous Cystinuria
Dietary Guidelines: Gaucher Disease Type 1 Patients Taking Miglustat
7 Common Characteristics of a Specialty Drug
Tackling the Challenge of Health Literacy, One Word at a Time
Living with Duchenne Muscular Dystrophy: Tommy’s Poem
7 Facts to Know About DMD on World Duchenne Awareness Day
Three Reasons Why Newborn Screening Awareness Month is More Important than Ever
Orsini Specialty Pharmacy Selected By Sanofi As A Limited Distribution Partner For Nexviazyme®
6 Metrics to Track Specialty Pharmacy Patient Satisfaction
7 Ways to Support Caregivers During National Family Caregivers Month
[Video] Rare Disease Day: What’s Your Why
Adding {{itemName}} to cart
Added {{itemName}} to cart
Loading...
×